Life Sciences Attorney John Harre Joins Foley Hoag as Partner

May 5, 2021

John Harre has joined Foley Hoag LLP as a partner in the Business Department concentrating his practice on the life sciences. He is resident in the firm’s Boston office.

Harre advises clients on business matters involving intellectual property issues, including mergers and acquisitions, investments and litigation, and assists them in the negotiation of licensing agreements and strategic collaborations.

"We are very pleased to welcome John to the firm and to our Life Sciences group," said Foley Hoag Co-Managing Partner Jeffrey Collins. "Drawing on over 25 years of experience that includes senior in-house counsel and executive leadership roles, he will be a tremendous asset to our clients in the biotechnology, pharmaceuticals and medical devices industries."

Prior to joining Foley Hoag, Harre was special counsel in the Boston office of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo where he concentrated on complex transactional matters for life sciences companies. He previously served as the global head and vice president of intellectual property and as general counsel and head of business development for a Boston-based biopharmaceutical company and a Cambridge-based biopharmaceutical company, respectively.

Harre earned a Bachelor of Arts degree in Biology from the University of Missouri; a Master of Science degree in Biotechnology from the University of Tennessee; and a Juris Doctorate from UNH Franklin Pierce School of Law. 

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.